HOME > BUSINESS > Article

Text Size

small

medium

large


Mitsubishi Chemical to Sell Drug Unit to Bain Capital

Mitsubishi Chemical to Sell Drug Unit to Bain Capital

   Tokyo, Feb. 7 (Jiji Press)--Mitsubishi Chemical Group Corp. said Friday that it will sell subsidiary Mitsubishi Tanabe Pharma Corp. to U.S. investment firm Bain Capital LP. for about 510 billion yen.
   Through the sale, which is expected to be completed by September, the Japanese group plans to focus on its core chemical business, including materials related to semiconductors. Meanwhile, the drug company will aim for growth by securing necessary funds for drug development under Bain Capital.

To read a full story, please click here to find out how to subscribe.

BUSINESS

HEADLINES

POLITICS
US Names Prosecutor Khan as 1st Target of Sanctions on ICC
ECONOMY
US Fed's Powell Sees No Need to Rush Interest Rate Cuts
SPORTS
IOC Decides to Hold 1st Olympic Esports Games in Riyadh in 2027
OTHER
SDF Joint Staff Vice Chief Nagumo to Head SDF's New Joint Operations Command

AFP-JIJI PRESS NEWS JOURNAL


Photos